FDA Refuses Booster Shot For All Americans But Senior Citizens Only

After a full day of contemplations, questions answers, presentations, and deliberations, the FDA rejected Joe Biden’s Pfizer booster plan for Americans. Instead, a third shot will be administered to elderly Americans only when required. Federal advisers voted 18-0 in favor of recommending Pfizer booster shots for anyone over 65 or anyone who is at high risk of severe disease but declined to recommend it for all Americans.

With the variants challenging the efficacy of the vaccine itself, Biden had chosen the booster shot route for health safety of the masses. If needed, the booster will be administered only six months after having received the second shot.

Pfizer has shared data that the efficacy and protection of the vaccine do tend to wane off with time, as seen in Israel’s case. But the reason FDA approval has been halted over booster shots is the lack of safety data when it comes to younger Americans.

Related Posts

While on one side Biden made a commitment that the booster drive does not start without clearance from regulators, his recent speech advocated for a booster campaign start from September 20. If the FDA signs off on the latest plan for boosters for seniors and health care workers, the CDC also has to weigh in. A key meeting is planned soon by a separate group of experts that advises the CDC and will likely discuss who exactly should get the extra doses.

After that CDC recommendation is made, booster shots would be available through any of the nation’s 40,000 pharmacies, doctors’ offices, and other sites already offering the Pfizer vaccine. Data collected from Israel shows excellent results of booster shots administered amongst senior citizens.

An Israeli study published in a British journal said that there were 11-fold lower rates of infection and nearly 20-fold lower rates of severe Covid-19 among people older than 60 who got a booster dose. A separate Israel Ministry of Health analysis estimated approximately 10-fold improved protection against infection and severe Covid-19 among people who got a booster.

UJM

Recent Posts

Why UK Film Students Are Studying Cary-Hiroyuki Tagawa’s Acting Techniques

Global film legends are being used by British film schools to redefine the manner in which future actors train their… Read More

December 5, 2025

Aviation Bottlenecks: Edinburgh Airport, Why it Became a Case Study in 2025

When the rise in customer numbers was met with low capacity to carry them, Edinburgh Airport became a high-profile symbol… Read More

December 5, 2025

World Health Organization Unveils 2026 Guidelines on New Obesity Medicines

The World Health Organization (WHO) has released its first global guidelines for the use of new obesity medicines, marking a… Read More

December 5, 2025

Military Demand vs. Renewable Future: The Global Rush for Critical Minerals — Can Climate & Security Co-exist?

The global race for critical minerals has intensified as countries push toward clean energy while simultaneously expanding military capabilities. Lithium,… Read More

December 5, 2025

Sustainability vs Fast Fashion: Why the Fashion Industry’s Environmental & Labour Impact Still Matters

The entertainment around the global fashion industry is facing increased scrutiny as the consumers get to know more about the… Read More

December 5, 2025

Hotel Deals & Travel Discounts in Japan: What Japan’s ‘GoGo Sale’ Means for Holiday-Season Bookers

The GoGo Sale of Japan is aimed at stimulating domestic and inbound tourism by offering time-promotion discounts on hotels, transport,… Read More

December 5, 2025

This website uses cookies.

Read More